LevelJump Announces 2025 Second Quarter Results
LevelJump Healthcare (TSXV: JUMP) has released its Q2 2025 financial results, showing consistent growth in revenues and operational performance. The company reported Q2 2025 revenues of $4.7 million, up 6.2% from the previous year, and six-month revenues of $9.3 million, representing a 9.4% increase year-over-year.
The company's subsidiary, Canadian Teleradiology Services, achieved an EBITDA of $1.01 million in Q2 and $2.23 million for the six-month period. Additionally, LevelJump is proceeding with its previously announced acquisition of two diagnostic imaging clinics in Calgary, with the transaction expected to close by October 2025.
LevelJump Healthcare (TSXV: JUMP) ha pubblicato i risultati finanziari del secondo trimestre 2025, confermando una crescita regolare dei ricavi e delle performance operative. L'azienda ha registrato ricavi del Q2 2025 pari a 4,7 milioni di dollari, in aumento del 6,2% rispetto all'anno precedente, e ricavi nei sei mesi pari a 9,3 milioni di dollari, con una crescita del 9,4% anno su anno.
La controllata Canadian Teleradiology Services ha ottenuto un EBITDA di 1,01 milioni di dollari nel Q2 e 2,23 milioni di dollari nel periodo di sei mesi. Inoltre, LevelJump sta portando avanti l'acquisizione annunciata di due cliniche di diagnostica per immagini a Calgary, con chiusura prevista entro ottobre 2025.
LevelJump Healthcare (TSXV: JUMP) ha dado a conocer sus resultados financieros del segundo trimestre de 2025, mostrando un crecimiento sostenido en ingresos y desempe帽o operativo. La compa帽铆a report贸 ingresos del Q2 2025 por 4,7 millones de d贸lares, un 6,2% m谩s que el a帽o anterior, y ingresos de seis meses por 9,3 millones de d贸lares, un incremento interanual del 9,4%.
La filial Canadian Teleradiology Services alcanz贸 un EBITDA de 1,01 millones de d贸lares en el Q2 y 2,23 millones de d贸lares en el periodo de seis meses. Adem谩s, LevelJump avanza con la adquisici贸n anunciada de dos cl铆nicas de imagen diagn贸stica en Calgary, cuyo cierre se espera para octubre de 2025.
LevelJump Healthcare (TSXV: JUMP)臧� 2025雲� 2攵勱赴 鞁れ爜鞚� 氚滍憸頃橂┌ 毵れ稖瓿� 鞖挫榿 靹标臣臧� 昃胳頌� 靹膘灔頄堨潓鞚� 氤挫榾鞀惦媹雼�. 須岇偓電� 2025雲� 2攵勱赴 毵れ稖 470毵� 雼煬毳� 旮半頃� 鞝勲厔 雽�牍� 6.2% 歃濌皜頄堨溂氅�, 氚橁赴 毵れ稖 930毵� 雼煬搿� 鞝勲厔 霃欔赴 雽�牍� 9.4% 靸侅姽頄堨姷雼堧嫟.
鞛愴殞靷� Canadian Teleradiology Services電� 2攵勱赴 EBITDA 101毵� 雼煬, 靸侂皹旮� 223毵� 雼煬毳� 雼劚頄堨姷雼堧嫟. 霕愴暅 LevelJump電� 氚滍憸霅� 氚旍檧 臧欖澊 旌橁卑毽潣 歆勲嫧 鞓侅儊 韥措Μ雼� 霊� 瓿� 鞚胳垬毳� 歆勴枆 欷戩澊氅� 瓯半灅電� 2025雲� 10鞗旉箤歆� 毵堧毽悹 鞓堨爼鞛呺媹雼�.
LevelJump Healthcare (TSXV: JUMP) a publi茅 ses r茅sultats du deuxi猫me trimestre 2025, confirmant une croissance r茅guli猫re des revenus et des performances op茅rationnelles. La soci茅t茅 a d茅clar茅 des revenus du T2 2025 de 4,7 millions de dollars, en hausse de 6,2% par rapport 脿 l'ann茅e pr茅c茅dente, et des revenus sur six mois de 9,3 millions de dollars, soit une augmentation de 9,4% d'une ann茅e sur l'autre.
La filiale Canadian Teleradiology Services a r茅alis茅 un EBITDA de 1,01 million de dollars au T2 et de 2,23 millions de dollars sur la p茅riode de six mois. Par ailleurs, LevelJump poursuit l'acquisition annonc茅e de deux cliniques d'imagerie diagnostique 脿 Calgary, dont la cl么ture est pr茅vue d'ici octobre 2025.
LevelJump Healthcare (TSXV: JUMP) hat seine Finanzergebnisse f眉r das zweite Quartal 2025 ver枚ffentlicht und weist ein stetiges Wachstum bei Umsatz und operativer Leistung aus. Das Unternehmen meldete Quartalsums盲tze Q2 2025 in H枚he von 4,7 Mio. USD, ein Anstieg um 6,2% gegen眉ber dem Vorjahr, sowie Sechsmonatsums盲tze von 9,3 Mio. USD, was einem Anstieg von 9,4% gegen眉ber dem Vorjahr entspricht.
Die Tochtergesellschaft Canadian Teleradiology Services erzielte ein EBITDA von 1,01 Mio. USD im Q2 und 2,23 Mio. USD im Sechsmonatszeitraum. Zudem schreitet LevelJump mit der angek眉ndigten 脺bernahme von zwei radiologischen Diagnostikkliniken in Calgary voran; der Abschluss der Transaktion wird bis Oktober 2025 erwartet.
- None.
- Q2 2025 net loss of $(133,145)
- Delayed closing of Calgary clinics acquisition to October 2025
Toronto, Ontario--(Newsfile Corp. - August 29, 2025) - LevelJump Healthcare Corp. - (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce its financial results for the three months and six months ended June 30, 2025.
Financial and Operational Highlights
Revenues were
$4.7 million in the second quarter compared to$4.4 million in the same period the prior year, an increase of6.2% .For the six months ended June 30, 2025, revenues were
$9.3 million compared to$8.5 million in the same period in 2024, an increase of9.4% .Canadian Teleradiology Services, Inc., the Company's
100% owned subsidiary had EBITDA in the second quarter of$1.01 million .For the six months ended June 30, 2025, Canadian Teleradiology Services, Inc. had EBITDA of
$2.23 million .
2025 Second Quarter Financial Results
Revenues of
$4.7 million in the second quarter of 2025 with a net loss of$(133,145) .EBITDA of
$459,740 for the second quarter of 2025.Revenues of
$9.3 million for the six months ended June 30, 2025, with a net income of$65,727. EBITDA of
$1.36 million for the six months ended June 30, 2025.
Previously Announced Acquisition
The Company entered into an agreement to acquire two additional diagnostic imaging outpatient clinics located in Calgary, Alberta. The transaction is now expected to close before the end of October 2025. See the Company's news release dated June 13, 2025.
Management Comments
Mitch Geisler, CEO, commented, "We are very pleased with our strong Q2 results and year-over-year growth. We continue to focus on increasing clinic revenue with additional patients scans and other organic growth opportunities."
Non-IFRS Financial Measures
This news release contains financial terms (such as adjusted EBITDA) that are not considered in IFRS. Such financial measures, together with measures prepared in accordance with IFRS, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-IFRS measures may differ from other reporting issuers and therefore are unlikely to be comparable to similar measures presented by other companies. Further, these non-IFRS measures should not be considered in isolation or as a substitute for measures of performance or cash flows prepared in accordance with IFRS. These financial measures are included because management uses this information to analyze operating performance and liquidity.
For further details on the results, please refer to LevelJump's Management, Discussion and Analysis and Consolidated Financial Statements for the year ended December 31, 2024, which are available on the Company's website () and under the Company's profile on SEDAR ().
About LevelJump Healthcare
LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.
ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.
Mitchell Geisler
Chief Executive Officer
[email protected]
647-340-2020
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.
To view the source version of this press release, please visit
FAQ
What were LevelJump Healthcare's (TSXV: JUMP) Q2 2025 revenue results?
How much EBITDA did Canadian Teleradiology Services generate in Q2 2025?
What acquisitions is LevelJump Healthcare planning in 2025?
What was LevelJump's net income for the first six months of 2025?
How much did LevelJump's revenue grow in the first half of 2025?
